Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications
Brisa S. Fernandes, Johann Steiner, Bernstein Hg, et al.
Molecular Psychiatry (2015) Vol. 21, Iss. 4, pp. 554-564
Closed Access | Times Cited: 298

Showing 1-25 of 298 citing articles:

The role of inflammation in depression: from evolutionary imperative to modern treatment target
Andrew H. Miller, Charles L. Raison
Nature reviews. Immunology (2015) Vol. 16, Iss. 1, pp. 22-34
Open Access | Times Cited: 2886
Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters
Marco Del Giudice, Steven W. Gangestad
Brain Behavior and Immunity (2018) Vol. 70, pp. 61-75
Open Access | Times Cited: 603
Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls
Emanuele F. Osimo, Toby Pillinger, Irene Mateos Rodríguez, et al.
Brain Behavior and Immunity (2020) Vol. 87, pp. 901-909
Open Access | Times Cited: 598
Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels
Emanuele F. Osimo, Luke Baxter, Glyn Lewis, et al.
Psychological Medicine (2019) Vol. 49, Iss. 12, pp. 1958-1970
Open Access | Times Cited: 557
Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders
Symen Ligthart, Ahmad Vaez, Urmo Võsa, et al.
The American Journal of Human Genetics (2018) Vol. 103, Iss. 5, pp. 691-706
Open Access | Times Cited: 387
Nutritional psychiatry: the present state of the evidence
Wolfgang Marx, Genevieve Moseley, Michael Berk, et al.
Proceedings of The Nutrition Society (2017) Vol. 76, Iss. 4, pp. 427-436
Open Access | Times Cited: 331
Psychoneuroimmunology of Early-Life Stress: The Hidden Wounds of Childhood Trauma?
Andrea Danese, Stephanie J. Lewis
Neuropsychopharmacology (2016) Vol. 42, Iss. 1, pp. 99-114
Open Access | Times Cited: 324
Inflammatory Biomarkers and Risk of Schizophrenia
Fernando Pires Hartwig, Maria Carolina Borges, Bernardo Lessa Horta, et al.
JAMA Psychiatry (2017) Vol. 74, Iss. 12, pp. 1226-1226
Open Access | Times Cited: 266
Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies
Brisa S. Fernandes, Marc L. Molendijk, Cristiano A. Köhler, et al.
BMC Medicine (2015) Vol. 13, Iss. 1
Open Access | Times Cited: 264
Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis
David Fraguas, Covadonga M. Díaz‐Caneja, Miriam Ayora, et al.
Schizophrenia Bulletin (2018) Vol. 45, Iss. 4, pp. 742-751
Open Access | Times Cited: 223
C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis
Brisa S. Fernandes, Johann Steiner, Marc L. Molendijk, et al.
The Lancet Psychiatry (2016) Vol. 3, Iss. 12, pp. 1147-1156
Closed Access | Times Cited: 209
Microbiome, inflammation, epigenetic alterations, and mental diseases
Reza Alam, Hamid M. Abdolmaleky, Jin‐Rong Zhou
American Journal of Medical Genetics Part B Neuropsychiatric Genetics (2017) Vol. 174, Iss. 6, pp. 651-660
Open Access | Times Cited: 208
Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review
Błażej Misiak, Bartłomiej Stańczykiewicz, Kamila Kotowicz, et al.
Schizophrenia Research (2017) Vol. 192, pp. 16-29
Closed Access | Times Cited: 182
Cytokines, Oxidative Stress and Cellular Markers of Inflammation in Schizophrenia
Rachel Upthegrove, Golam M. Khandaker
Current topics in behavioral neurosciences (2019), pp. 49-66
Closed Access | Times Cited: 178
Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study
Bram P. Prins, Ali Abbasi, Anson Wong, et al.
PLoS Medicine (2016) Vol. 13, Iss. 6, pp. e1001976-e1001976
Open Access | Times Cited: 177
Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models
Toby Pillinger, Enrico D’Ambrosio, Robert A. McCutcheon, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 6, pp. 776-794
Open Access | Times Cited: 170
Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders
André F. Carvalho, Marco Solmi, Marcos Sanches, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 169
Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis
Sean Halstead, Dan Siskind, Michaela Amft, et al.
The Lancet Psychiatry (2023) Vol. 10, Iss. 4, pp. 260-271
Closed Access | Times Cited: 119
Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives
Evgeny A. Ermakov, Mark M. Melamud, Valentina N. Buneva, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 92
The schizophrenia syndrome, circa 2024: What we know and how that informs its nature
Rajiv Tandon, Henry A. Nasrallah, Schahram Akbarian, et al.
Schizophrenia Research (2023) Vol. 264, pp. 1-28
Open Access | Times Cited: 59
The Microbiota, Immunoregulation, and Mental Health: Implications for Public Health
Christopher A. Lowry, David Glenn Smith, Philip H. Siebler, et al.
Current Environmental Health Reports (2016) Vol. 3, Iss. 3, pp. 270-286
Open Access | Times Cited: 165
Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions
Brian J. Miller, David R. Goldsmith
Neuropsychopharmacology (2016) Vol. 42, Iss. 1, pp. 299-317
Open Access | Times Cited: 159
A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis
Toby Pillinger, Emanuele F. Osimo, Stefan Brugger, et al.
Schizophrenia Bulletin (2018) Vol. 45, Iss. 5, pp. 1120-1133
Open Access | Times Cited: 152
Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder
Danny Boerrigter, Thomas W. Weickert, Rhoshel Lenroot, et al.
Journal of Neuroinflammation (2017) Vol. 14, Iss. 1
Open Access | Times Cited: 146
Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: A systematic review and meta-analysis
Błażej Misiak, Bartłomiej Stańczykiewicz, Łukasz Łaczmański, et al.
Schizophrenia Research (2017) Vol. 190, pp. 18-27
Closed Access | Times Cited: 140
Page 1 - Next Page

Scroll to top